Lapatinib Etibo 250mg 30 Tablet

Get a Price/Quote

MOQ : 10 Pieces

Lapatinib Etibo 250mg 30 Tablet Specification

Brand Name
Etibo

Salt Composition
Lapatinib

Pacakaging (Quantity Per Box)
30 Tablets per box

Life Span
Check strip/box for expiry date

Packaging Type
Box

Indication
Breast cancer, specifically HER2-positive metastatic breast cancer

Origin of Medicine
India

Dosage Form
Tablet

Drug Type
Prescription drug

Ingredients
Lapatinib

Physical Form
Tablet

Function
Anti-cancer medication (Tyrosine kinase inhibitor)

Recommended For
Patients with breast cancer

Dosage
250mg per tablet

Dosage Guidelines
As directed by a physician

Suitable For
Adults

Quantity
30 Tablets

Storage Instructions
Store in a cool and dry place, away from sunlight

Route of Administration
Oral

Therapeutic Class
Oncology

Shelf Life
2 years from date of manufacture

Strength
250 mg

Prescription Required
Yes

Marketed By
Intas Pharmaceuticals

Country of Export
Canada, Europe, UK, USA, Australia (as shown)

About Lapatinib Etibo 250mg 30 Tablet

Lapatinib Etibo 250mg is an unassailable choice for those seeking to procure advanced therapy for HER2-positive metastatic breast cancer. Manufactured by Intas Pharmaceuticals in India, this anti-cancer virtuoso features a potent 250 mg dosage of Lapatinib per tablet and is provided in a convenient box of 30 tablets. Etibo is highly recommended by oncology professionals for its sublime efficacy and affordability. Administered orally, this medication is suitable for adults when prescribed by a physician and ensures an extended shelf life of 2 years. Store securely in a cool, dry place.

Applications & Usage of Lapatinib Etibo 250mg

Lapatinib Etibo 250mg is meticulously designed for plant application in pharmaceutical oncology settings, primarily targeting HER2-positive metastatic breast cancer. Its type of usage is strictly oral, and it is recommended exclusively for adults, as directed by healthcare professionals. The versatile application areas encompass hospitals and cancer care facilities across Canada, Europe, the UK, the USA, and Australia, making it a global solution for effective cancer therapy.

Certifications, Market Coverage & Supply Efficiency

Lapatinib Etibo 250mg is registered with stringent certifications ensuring quality and efficacy for international markets. It prominently serves the main domestic market of India while being exported to key regions worldwide. With robust supply ability, Etibo is readily available at an affordable sale price versus the standard list price, and distributors can expect a quick dispatch from trusted manufacturers, suppliers, and traders across India.

FAQ's of Lapatinib Etibo 250mg 30 Tablet:

Q: How should Lapatinib Etibo 250mg tablets be administered?

A: Lapatinib Etibo should be taken orally, following the dosage and schedule prescribed by your healthcare provider. Always use this medication exactly as directed for optimal results.

Q: What is the main benefit of using Lapatinib Etibo 250mg for breast cancer patients?

A: Lapatinib Etibo provides targeted therapy for patients with HER2-positive metastatic breast cancer, helping to inhibit the growth of cancer cells and improve treatment outcomes.

Q: When is Lapatinib Etibo 250mg recommended for use?

A: This medication is recommended for adult patients diagnosed with HER2-positive metastatic breast cancer, as determined by an oncologist.

Q: Where is Lapatinib Etibo 250mg manufactured and supplied?

A: Etibo is manufactured by Intas Pharmaceuticals in India and is exported to Canada, Europe, the UK, the USA, and Australia.

Q: What storage instructions should be followed for Lapatinib Etibo 250mg tablets?

A: Store Lapatinib Etibo tablets in a cool and dry place, away from direct sunlight, and always check the strip or box for the expiry date before use.

Q: How can medical professionals procure Lapatinib Etibo 250mg tablets?

A: Medical professionals can procure Etibo through certified manufacturers, suppliers, or traders in India, ensuring access to an affordable, highly recommended cancer therapy.

Tell us about your requirement